DESIGN THERAPEUTICS INC shareholders Q3 2023

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

DESIGN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Covestor Ltd 17$00.00%
Point72 Middle East FZE 4,925$11,6230.00%
JPMORGAN CHASE & CO 56,342$132,9670.00%
BARCLAYS PLC 71,678$1700.00%
ROYAL BANK OF CANADA 5,501$13,0000.00%
D. E. Shaw & Co., Inc. 11,740$27,7060.00%
VANGUARD GROUP INC 986,711$2,328,6380.00%
Ameritas Investment Partners, Inc. 2,570$6,0650.00%
FEDERATED HERMES, INC. 2,873$6,7800.00%
JANE STREET GROUP, LLC 29,383$69,3440.00%
VOYA INVESTMENT MANAGEMENT LLC 14,090$33,2520.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 7,231$17,0650.00%
Cubist Systematic Strategies, LLC 26,937$63,5710.00%
Point72 Asset Management, L.P. 1$20.00%
UBS Group AG 18,064$42,6310.00%
ALLIANCEBERNSTEIN L.P. 41,400$97,7040.00%
RHUMBLINE ADVISERS 52,476$123,8350.00%
PRUDENTIAL FINANCIAL INC 18,415$43,4590.00%
Glassman Wealth Services 565$1,3330.00%
Squarepoint Ops LLC 42,562$100,4460.00%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q3 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.